These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3517417)

  • 1. [Cell differentiation induction therapy in leukemia].
    Tashima M; Sawada H; Okazaki T; Mochizuki T; Ishikura H; Izumi Y; Uchino H
    Nihon Rinsho; 1986 Feb; 44(2):388-94. PubMed ID: 3517417
    [No Abstract]   [Full Text] [Related]  

  • 2. [Induction of cellular differentiation in the treatment of acute leukemias: preliminary report of the use of low doses of cytosine arabinoside for the induction of remission].
    Marín-López A; Lobato-Mendizábal E; Munive-Ordóñez I; Ruiz-Argüelles GJ
    Rev Invest Clin; 1984; 36(3):247-51. PubMed ID: 6515157
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fundamentals of leukemia differentiation therapy].
    Hozumi M
    Rinsho Ketsueki; 1992 May; 33(5):561-72. PubMed ID: 1630006
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential applications of cytodifferentiation therapy in hematologic malignancies.
    Breitman TR; Chen ZX; Takahashi N
    Semin Hematol; 1994 Oct; 31(4 Suppl 5):18-25. PubMed ID: 7831581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To overcome pharmacologic and cytokinetic resistance to cytarabine in the treatment of acute myelogenous leukemia by using recombinant interleukin-3?
    Brach MA; Henschler R; Mertelsmann R; Herrmann F
    Semin Hematol; 1991 Jul; 28(3 Suppl 4):39-43. PubMed ID: 1780751
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental model for differentiation therapy of leukemia].
    Hayashi M
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1009-15. PubMed ID: 8099785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies.
    Kasukabe T; Honma Y; Hozumi M; Suda T; Nishii Y
    Cancer Res; 1987 Jan; 47(2):567-72. PubMed ID: 3466692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of the dormant state in an established cell line of human hematopoietic cells.
    Clarkson BD; Fried J; Chou TC; Strife A; Ferguson R; Sullivan S; Kitahara T; Oyama A
    Cancer Res; 1977 Dec; 37(12):4506-22. PubMed ID: 336195
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of prostaglandins in regulation of erythroleukemic cell proliferation and differentiation.
    Santoro MG
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():395-9. PubMed ID: 2936130
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intermediate-dose cytosine arabinoside therapy in refractory acute leukemia].
    Ohshima A; Yoshida K; Miyazaki S; Fukushima Y; Miura AB; Endo K; Ando H; Sasaki H; Saito S; Sato I
    Gan To Kagaku Ryoho; 1989 Jan; 16(1):139-42. PubMed ID: 2643393
    [No Abstract]   [Full Text] [Related]  

  • 11. [Growth inhibition and promotion of differentiation induction in cultured leukemia cell lines by deferoxamine].
    Tomoyasu S; Nakamaki T; Suzuki K; Tsuruoka N
    Nihon Ketsueki Gakkai Zasshi; 1987 May; 50(3):568-74. PubMed ID: 3425174
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytosine arabinoside as a polyvalent drug in the treatment of acute non-lymphoid leukemias].
    Sánchez Fayos J
    Sangre (Barc); 1986; 31(5):566-73. PubMed ID: 3810411
    [No Abstract]   [Full Text] [Related]  

  • 13. Properties of antileukaemic drugs.
    Brusamolino E
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():30-3. PubMed ID: 2653515
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
    Niitsu N; Ishii Y; Matsuda A; Honma Y
    Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute promyelocytic leukemia: biology and treatment.
    Fenaux P; Chomienne C; Degos L
    Semin Oncol; 1997 Feb; 24(1):92-102. PubMed ID: 9045308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation therapy for acute promyelocytic leukemia.
    Fenaux P; Degos L
    N Engl J Med; 1997 Oct; 337(15):1076-7. PubMed ID: 9321537
    [No Abstract]   [Full Text] [Related]  

  • 17. [Control of the induction of differentiation in Friend leukemia cells].
    Obinata M
    Nihon Rinsho; 1986 Feb; 44(2):299-304. PubMed ID: 3702066
    [No Abstract]   [Full Text] [Related]  

  • 18. Differentiating agents in the treatment of leukemia and myelodysplastic syndromes.
    Degos L
    Leuk Res; 1990; 14(8):731-3. PubMed ID: 2201824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-trans-retinoic acid in acute promyelocytic leukemia.
    Tallman MS; Andersen JW; Schiffer CA; Appelbaum FR; Feusner JH; Ogden A; Shepherd L; Willman C; Bloomfield CD; Rowe JM; Wiernik PH
    N Engl J Med; 1997 Oct; 337(15):1021-8. PubMed ID: 9321529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoids in the treatment of acute promyelocytic leukemia. Review of the literature.
    Graf N; Riesinger P; Reinhard H
    Klin Padiatr; 1995; 207(2):43-7. PubMed ID: 7752598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.